Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer

Phase 1

Completed

Conditions: Prostate Cancer

First Posted Date: 2004-06-09

Last Posted Date: 2013-06-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT00006380

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

BMS-214662 in Treating Patients With Advanced Solid Tumors

Phase 1

Completed

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2004-06-04

Last Posted Date: 2009-12-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT00004877

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Ro 31-7453 in Treating Patients With Locally Advanced or Metastatic Solid Tumor

Phase 1

Completed

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2004-06-03

Last Posted Date: 2013-06-25

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 40

Registration Number: NCT00003755

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Phase 2

Completed

Conditions: Head and Neck Cancer

First Posted Date: 2004-06-03

Last Posted Date: 2013-06-24

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT00003443

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Trastuzumab in Treating Patients With Prostate Cancer

Phase 2

Completed

Conditions: Prostate Cancer

First Posted Date: 2004-06-03

Last Posted Date: 2013-06-21

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT00003740

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Arsenic Trioxide in Treating Patients With Metastatic Kidney Cancer

Phase 2

Completed

Conditions: Kidney Cancer

First Posted Date: 2004-05-26

Last Posted Date: 2013-06-19

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT00005069

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by Surgery

Phase 3

Completed

Conditions: Malignant Mesothelioma

First Posted Date: 2004-05-26

Last Posted Date: 2013-06-19

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT00005636

Locations: 🇺🇸
Ireland Cancer Center, Cleveland, Ohio, United States
🇺🇸
Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer

Phase 2

Completed

Conditions: Leukemia
Lymphoma
Oral Complications

First Posted Date: 2004-05-25

Last Posted Date: 2013-06-26

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 111

Registration Number: NCT00004061

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Capecitabine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase 2

Completed

Conditions: Fallopian Tube Cancer
Ovarian Cancer
Primary Peritoneal Cavity Cancer

First Posted Date: 2004-05-25

Last Posted Date: 2013-06-24

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT00004012

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

High-Dose Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia in Remission

Phase 2

Completed

Conditions: Bone Marrow Ablation
Leukemia

First Posted Date: 2004-05-24

Last Posted Date: 2013-06-27

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 45

Registration Number: NCT00002567

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy